BioCentury
ARTICLE | Clinical News

Vestar Inc. regulatory update

January 16, 1995 8:00 AM UTC

Vestar Inc. (VSTR) The San Dimas, Calif., company filed an amendment to its NDA for DaunoXome liposomal daunorubicin to treat Kaposi's sarcoma. The amendment includes results and analysis of a Phase ...